Adaptive Biotechnologies Triples Footprint

Adaptive Biotechnologies has unveiled plans to lease a new corporate headquarters with a state-of-the-art office space and research facility that will triple the company’s Seattle footprint.  Adaptive has signed a 12-year, full-building, 100,000 square foot lease with long-time partner Alexandria Real Estate Equities, Inc. at 1165 Eastlake Avenue East, in the heart of Seattle’s Lake Union life science cluster.
 
"We have worked with Alexandria to design a state-of-the-art headquarters that will allow us to expand our lab capacity, R&D footprint, and office space to help realize our goal to translate the genetics of the adaptive immune system into clinical products that we believe will transform medicine and improve patients’ lives," said Chad Robins, chief executive officer and co-founder, Adaptive. "This space will support Adaptive’s strategic growth trajectory, provide our current and future employees with improved space and amenities, and foster our mission-driven culture that drives commitment to each other, our customers, and our patients."
 
Adaptive’s current headquarters, 1551 Eastlake Avenue East, also part of The Eastlake Life Science Campus by Alexandria, is a short distance from the future facility. Shell construction of the new building is expected to be completed in 2020 and Adaptive plans to occupy the new building in 2021 once interior construction is finished. Over the past decade, Adaptive has focused on building their proprietary immune medicine platform, clinical immunomics database and infrastructure. The company is experiencing significant growth as it transitions to leveraging the platform towards developing truly personalized, patient-specific, immune-driven clinical products.

-----------------------------------------------------------------------
Editor's Note:

If you have any suggestion to the content, 

please email: Julia.Zhang@ubmsinoexpo.com